VTGN
VistaGen Therapeutics Inc
0.273$
-7.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.07 | 0.00 | 4.98 | 0.00 | 0.00 | 0.23 | 0.38 | 0.17 | -0.03 | 0.05 | 0.02 | 0.03 | |
| 0.00 | 0.91 | 45.58 | 0.17 | 0.10 | 0.07 | – | 0.12 | 0.07 | 0.03 | 0.02 | – | |
| -3.07 | 0.00 | 4.98 | 0.00 | -0.10 | -0.07 | 0.38 | 0.17 | -0.03 | 0.05 | 0.02 | 0.03 | |
| 55.34 | 66.71 | 20.73 | 16.77 | 17.96 | 9.11 | 4.15 | 5.37 | 6.38 | 1.03 | 1.28 | 1.44 | |
| 96.59 | 236.18 | 23.37 | 13.90 | 7.81 | 4.51 | 2.47 | 1.58 | 2.11 | 0.73 | 0.55 | 0.48 | |
| 151.93 | 302.89 | 45.80 | 30.67 | 25.77 | 13.59 | 6.63 | 7.41 | 8.48 | 1.76 | 1.83 | 1.93 | |
| -154.17 | -302.89 | -40.82 | -30.67 | -25.79 | -13.66 | -6.25 | -7.24 | -8.52 | -1.71 | -1.81 | -1.89 | |
| 105.03 | 13.18 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.04 | 0.00 | – | – | – | |
| -315.82 | -801.23 | -40.84 | -30.98 | -25.82 | -14.20 | -6.25 | -7.24 | -8.51 | -1.52 | -1.67 | -1.83 | |
| 0.05 | 0.04 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -315.87 | -801.27 | -40.85 | -30.98 | -25.83 | -14.21 | -6.25 | -7.24 | -8.51 | -1.52 | -1.67 | -1.83 | |
| -152.82 | -301.99 | -38.90 | -30.49 | -25.70 | -14.12 | -6.07 | -7.13 | -8.44 | -1.49 | -1.64 | -1.88 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.